GTF2IRD2P: Potential Drug Target for Alzheimer's? (G401375)

Target Name: GTF2IRD2P1

NCBI ID: G401375

GTF2IRD2P1

Other Name(s): GTF2IRD2P | GTF2I repeat domain containing 2 pseudogene 1

GTF2IRD2P: Potential Drug Target for Alzheimer's?

GTF2IRD2P1, also known as GTF2IRD2P, is a protein that is expressed in the brain and is known for its role in the development and progression of various neurological disorders, including Alzheimer's disease. The GTF2IRD2P gene has been identified as a potential drug target (or biomarker) for the treatment of these disorders.

The GTF2IRD2P protein is a member of the GTF2 family, which is known for its role in the development and progression of various neurological disorders. The GTF2IRD2P protein is expressed in the brain and is involved in the formation of the blood-brain barrier, which is a barrier that separates the brain from the surrounding blood vessels. The formation of the blood-brain barrier is critical for the protection of the brain and is a key factor in the development of neurodegenerative diseases.

Studies have shown that mice that are genetically modified to lack the GTF2IRD2P protein have reduced levels of the neurotoxin 尾-amyloid, which is a hallmark of Alzheimer's disease. This suggests that the GTF2IRD2P protein may be involved in the development and progression of Alzheimer's disease.

In addition to its role in the formation of the blood-brain barrier, GTF2IRD2P has also been shown to play a role in the regulation of the immune response. Studies have shown that the GTF2IRD2P protein is involved in the development of an immune response in the brain, which may contribute to the development of neurodegenerative diseases.

The GTF2IRD2P protein is also involved in the regulation of the blood-brain barrier in a way that may be relevant to the treatment of neurodegenerative diseases. The blood-brain barrier is a barrier that separates the brain from the surrounding blood vessels, and it is difficult to access the brain with drugs. However, studies have shown that the GTF2IRD2P protein plays a role in the regulation of the blood-brain barrier, which may be important for the development of effective treatments for neurodegenerative diseases.

In conclusion, GTF2IRD2P1 is a protein that is expressed in the brain and is involved in the formation of the blood-brain barrier, the regulation of the immune response, and the regulation of the blood-brain barrier. The GTF2IRD2P protein may be a drug target (or biomarker) for the treatment of neurodegenerative diseases, including Alzheimer's disease. Further research is needed to fully understand the role of the GTF2IRD2P protein in the development and progression of these disorders.

Protein Name: GTF2I Repeat Domain Containing 2 Pseudogene 1

The "GTF2IRD2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GTF2IRD2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets